ResearcherNorthern Jiangsu People's HospitalActive in the last 2 years
Jie Zhu
Matched on OpenAlex author ID A5100589160. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2023: 1 paper · 2024: 2 papers · 2025: 1 paper
Papers 4
- Targeting protein modification: a new direction for immunotherapy of pancreatic cancer. Co-author DOI 10.7150/ijbs.101861↗
- Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer. Co-author DOI 10.1186/s12967-024-05307-3↗
- Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization. First author DOI 10.3389/fimmu.2024.1402113↗
- Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer. Co-author DOI 10.3389/fmed.2023.1213136↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xinyu Ge · 4 shared papers, 2023–2025 · strength 0.92
- Paper Targeting protein modification: a new direction for immunotherapy of pancreatic cancer. DOI 10.7150/ijbs.101861↗
- Paper Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment o… DOI 10.1186/s12967-024-05307-3↗
- Paper Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer. DOI 10.3389/fmed.2023.1213136↗
- Jie J. Yao · 4 shared papers, 2023–2025 · strength 0.92
- Paper Targeting protein modification: a new direction for immunotherapy of pancreatic cancer. DOI 10.7150/ijbs.101861↗
- Paper Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment o… DOI 10.1186/s12967-024-05307-3↗
- Paper Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer. DOI 10.3389/fmed.2023.1213136↗
- Ke Zhang · 2 shared papers, 2023–2025 · strength 0.47
- Ke Zhang · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.